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Abstract
The paper summarizes the literature data on the biological activity of organoarsenic derivatives,
describes compounds with useful biological properties necessary for their use in medicines, and
presents  the results  of  the study of  arylated arsenic  compounds as  stimulants  of  cardiac
activity. A stable view of the high toxicity of organoarsenic compounds interfered with their
practical use. Existing data on the biological properties of organoarsenic compounds do not give
a complete and unambiguous idea of the possibilities of their application. In this connection, this
paper was aimed at generalizing the available data on the biological activity of organoarsenic
derivatives and obtaining compounds with practically useful properties suitable for their use in
medicine. The biological significance of arsenic in the body is determined by its participation in
the metabolism. He plays an important role in the enzymatic reactions of tissue respiration. In
the light of these concepts, its therapeutic significance is regarded. The action of arsenic was
considered as a result of its influence on the vessels through the sympathetic nervous system.
With therapeutic doses of arsenic, this is expressed in the expansion of blood vessels and
contributes to the improvement of trophism. Administration of high doses results in stagnation
of blood, inflammation and even necrosis of the walls of the capillaries.
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